INS and Alzheimer disease: We specifically aimed to identify one phenotype of AD: individuals with non-insulin-dependent diabetes and no history of obesity, metabolic syndrome, or other known cause of insulin resistance, which we have termed “insulin-sufficient, non-metabolic” (ISNM) diabetes.